HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$20.69
Day range
$20.50 - $22.66
Year range
$10.00 - $28.42
Market cap
240.70M USD
Avg Volume
179.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 7.31M | 112.01% |
Net income | -52.31M | -1,527.98% |
Net profit margin | — | — |
Earnings per share | -5.38 | -572.50% |
EBITDA | -54.14M | -524.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 189.82M | 430.56% |
Total assets | 214.80M | 220.45% |
Total liabilities | 51.49M | -31.57% |
Total equity | 163.31M | — |
Shares outstanding | 10.95M | — |
Price to book | 1.39 | — |
Return on assets | -71.84% | — |
Return on capital | -94.57% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -52.31M | -1,527.98% |
Cash from operations | -29.41M | -131.21% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 98.20M | 1,227,462.50% |
Net change in cash | 68.79M | 633.59% |
Free cash flow | -18.52M | -274.82% |
About
Founded
2012
Headquarters
Website
Employees
38
